Alere Inc. (NYSE: ALR)

https://www.alere.com

Headquartered in Waltham, Mass., Alere is the global leader in point of care diagnostics with annual sales of $2.5 billion. Alere delivered more than 1.4 billion tests at the point of care in 2015. Its fast, easy-to-use and cost-effective tests are focused on the areas of infectious disease, molecular, cardiometabolic and toxicology. In addition to tests for infections such as HIV, tuberculosis, malaria and dengue that can benefit people in remote care settings, Alere develops simple, rapid tests, including Alere i, the first molecular CLIA-waived test for flu and strep, that delivers results in under 15 minutes. *

	Start	2010-07-15 renamed
	Group	Abbott (Group)
	Predecessor	Inverness Medical (Group)
	Industry	diagnostics (medical/biological)
	Industry 2	diagnostic test, rapid (point-of-care)

	Region	Waltham, MA
	Country	United States (USA)
	Street	51 Sawyer Road Suite 200
	City	02453 Waltham, MA
		Address record changed: 2020-12-02

Basic data	Employees	G: 5,001 to 10,000 (2016-02-01)
	Currency	USD
	Annual sales	2,500,000,000 (sales 2015-12-31)

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Abbott (Group)

[1] Biotage AB. (5/24/19). "Press Release: Tomas Blomquist – New CEO & President of Biotage". Uppsala....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com